This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
New Strong Sell Stocks for August 8th
by Zacks Equity Research
ASH, BASFY and ASB have been added to the Zacks Rank #5 (Strong Sell) List on August 8, 2023.
Ashland's (ASH) Earnings and Sales Miss Estimates in Q3
by Zacks Equity Research
The sales of Ashland (ASH) are adversely impacted by lower volumes from customer inventory destocking, partly offset by favorable pricing in Q3.
Ashland (ASH) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Ashland (ASH) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Ashland (ASH) Lags Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Ashland (ASH) delivered earnings and revenue surprises of -12.14% and 0.21%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for July 25th
by Zacks Equity Research
ASH, CTS and CP have been added to the Zacks Rank #5 (Strong Sell) List on July 25, 2023.
Earnings Preview: Element Solutions (ESI) Q2 Earnings Expected to Decline
by Zacks Equity Research
Element Solutions (ESI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for July 19th
by Zacks Equity Research
ASH, BASFY and BGC have been added to the Zacks Rank #5 (Strong Sell) List on July 19, 2023.
Analysts Estimate Ashland (ASH) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Ashland (ASH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for July 11th
by Zacks Equity Research
APELY, ASH and BASEY have been added to the Zacks Rank #5 (Strong Sell) List on July 11, 2023.
Ashland (ASH) Provides Key Updates on Q3 and FY23 Outlook
by Zacks Equity Research
Ashland (ASH) faces challenges stemming from customer de-stocking and macroeconomic uncertainties, as reflected in its Q3 preliminary results and updated outlook for fiscal year 2023.
Is the Options Market Predicting a Spike in Ashland (ASH) Stock?
by Zacks Equity Research
Investors need to pay close attention to Ashland (ASH) stock based on the movements in the options market lately.
Why Is Ashland (ASH) Down 6% Since Last Earnings Report?
by Zacks Equity Research
Ashland (ASH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Ashland (ASH) Raises Dividend, Announces Share Buyback Plan
by Zacks Equity Research
Ashland's (ASH) goal is to have an annual dividend payout ratio of about 30% of adjusted income from continuing operations.
Ashland's (ASH) Earnings and Revenues Lag Estimates in Q2
by Zacks Equity Research
Demand weakness in personal care and specialty additives and customer inventory destocking hurt Ashland's (ASH) Q2 results.
Ashland (ASH) Misses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Ashland (ASH) delivered earnings and revenue surprises of -6.54% and 4.67%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Element Solutions (ESI) Surpasses Q1 Earnings Estimates
by Zacks Equity Research
Element Solutions (ESI) delivered earnings and revenue surprises of 3.45% and 8.54%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Element Solutions (ESI) Q1 Earnings Expected to Decline
by Zacks Equity Research
Element Solutions (ESI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ashland (ASH) Earnings Expected to Grow: What to Know Ahead of Q2 Release
by Zacks Equity Research
Ashland (ASH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why You Should Add Ashland (ASH) Stock to Your Portfolio
by Zacks Equity Research
Ashland (ASH) gains on strong demand in its consumer end markets and its pricing actions to counter inflation.
Here's Why You Should Retain Ashland (ASH) Stock for Now
by Zacks Equity Research
Ashland (ASH) benefits from healthy demand in most consumer end markets, the Schulke & Mayr acquisition and its pricing and mix improvement actions to counter inflation.
Ashland (ASH) Gains on Pharma Business Strength & Pricing
by Zacks Equity Research
Ashland (ASH) benefits from strength in its global pharma business, the Schulke & Mayr acquisition and its pricing and mix improvement actions to counter inflation.
Why Is Ashland (ASH) Down 5.4% Since Last Earnings Report?
by Zacks Equity Research
Ashland (ASH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks Industry Outlook Highlights Ashland, Quaker Chemical and Flexible Solutions International
by Zacks Equity Research
Ashland, Quaker Chemical and Flexible Solutions International are part of the Zacks Industry Outlook article.
3 Chemical Specialty Stocks to Watch From a Challenging Industry
by Anindya Barman
Slowing end-market demand and input cost pressure mar prospects of the Zacks Chemicals Specialty industry. ASH, KWR and FSI are set to gain from self-help actions.
Ashland's (ASH) Earnings Beat Estimates in Q1, Revenues Lag
by Zacks Equity Research
While Ashland (ASH) gains on disciplined pricing actions, weaker demand in China and significant inventory destocking weigh on its Q1 performance.